Market Cap

Immunicum AB Market Capitalization:

kr448.8 Million

SEK as of Jan. 1, 2024

US$44.6 Million

business Immunicum AB Company Profile

Immunicum AB Main Stock Listing

OMX: IMMU

Market Capitalization History of Immunicum AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Immunicum AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr448.8 M -20.36%
Jan. 1, 2023 kr563.6 M -12.58%
Jan. 1, 2022 kr644.7 M -55.90%
Jan. 1, 2021 kr1.46 B -29.22%
Jan. 1, 2020 kr2.07 B 17.80%
Jan. 1, 2019 kr1.75 B 24.52%
Jan. 1, 2018 kr1.41 B -72.09%
Jan. 1, 2017 kr5.05 B -27.95%
Jan. 1, 2016 kr7.00 B 72.73%
Jan. 1, 2015 kr4.05 B -28.43%
Jan. 1, 2014 kr5.67 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Immunicum AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Immunicum AB has the following listings and related stock indices.


Stock: OMX: IMMU

Stock: FSX: 1YG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.